[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global PEGylated Proteins Market Professional Survey Report 2017

September 2017 | 104 pages | ID: G875B930652EN
QYResearch

US$ 3,500.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report studies PEGylated Proteins in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
  • ENZON Pharmaceuticals
  • Merck Sharp & Dohme
  • Roche
  • Pfizer
  • Amgen
  • UCB
  • Crealta (Savient)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Colony Stimulating Factors
  • Interferons
  • Erythropoietin (EPO)
  • Recombinant Factor Viii
  • Monoclonal Antibodies
  • Others
By Application, the market can be split into
  • Cancer Treatment
  • Hepatitis
  • Chronic Kidney Disease
  • Leukemia
  • SCID
  • Rheumatoid Arthritis & Crohn's Disease
  • Others
By Regions, this report covers (we can add the regions/countries as you want)
  • North America
  • China
  • Europe
  • Southeast Asia
  • Japan
  • India
If you have any special requirements, please let us know and we will offer you the report as you want.
Global PEGylated Proteins Market Professional Survey Report 2017

1 INDUSTRY OVERVIEW OF PEGYLATED PROTEINS

1.1 Definition and Specifications of PEGylated Proteins
  1.1.1 Definition of PEGylated Proteins
  1.1.2 Specifications of PEGylated Proteins
1.2 Classification of PEGylated Proteins
  1.2.1 Colony Stimulating Factors
  1.2.2 Interferons
  1.2.3 Erythropoietin (EPO)
  1.2.4 Recombinant Factor Viii
  1.2.5 Monoclonal Antibodies
  1.2.6 Others
1.3 Applications of PEGylated Proteins
  1.3.1 Cancer Treatment
  1.3.2 Hepatitis
  1.3.3 Chronic Kidney Disease
  1.3.4 Leukemia
  1.3.5 SCID
  1.3.6 Rheumatoid Arthritis & Crohn's Disease
  1.3.7 Others
1.4 Market Segment by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India

2 MANUFACTURING COST STRUCTURE ANALYSIS OF PEGYLATED PROTEINS

2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of PEGylated Proteins
2.3 Manufacturing Process Analysis of PEGylated Proteins
2.4 Industry Chain Structure of PEGylated Proteins

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF PEGYLATED PROTEINS

3.1 Capacity and Commercial Production Date of Global PEGylated Proteins Major Manufacturers in 2016
3.2 Manufacturing Plants Distribution of Global PEGylated Proteins Major Manufacturers in 2016
3.3 R&D Status and Technology Source of Global PEGylated Proteins Major Manufacturers in 2016
3.4 Raw Materials Sources Analysis of Global PEGylated Proteins Major Manufacturers in 2016

4 GLOBAL PEGYLATED PROTEINS OVERALL MARKET OVERVIEW

4.1 2012-2017E Overall Market Analysis
4.2 Capacity Analysis
  4.2.1 2012-2017E Global PEGylated Proteins Capacity and Growth Rate Analysis
  4.2.2 2016 PEGylated Proteins Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2012-2017E Global PEGylated Proteins Sales and Growth Rate Analysis
  4.3.2 2016 PEGylated Proteins Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2012-2017E Global PEGylated Proteins Sales Price
  4.4.2 2016 PEGylated Proteins Sales Price Analysis (Company Segment)

5 PEGYLATED PROTEINS REGIONAL MARKET ANALYSIS

5.1 North America PEGylated Proteins Market Analysis
  5.1.1 North America PEGylated Proteins Market Overview
  5.1.2 North America 2012-2017E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 North America 2012-2017E PEGylated Proteins Sales Price Analysis
  5.1.4 North America 2016 PEGylated Proteins Market Share Analysis
5.2 China PEGylated Proteins Market Analysis
  5.2.1 China PEGylated Proteins Market Overview
  5.2.2 China 2012-2017E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2012-2017E PEGylated Proteins Sales Price Analysis
  5.2.4 China 2016 PEGylated Proteins Market Share Analysis
5.3 Europe PEGylated Proteins Market Analysis
  5.3.1 Europe PEGylated Proteins Market Overview
  5.3.2 Europe 2012-2017E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Europe 2012-2017E PEGylated Proteins Sales Price Analysis
  5.3.4 Europe 2016 PEGylated Proteins Market Share Analysis
5.4 Southeast Asia PEGylated Proteins Market Analysis
  5.4.1 Southeast Asia PEGylated Proteins Market Overview
  5.4.2 Southeast Asia 2012-2017E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Southeast Asia 2012-2017E PEGylated Proteins Sales Price Analysis
  5.4.4 Southeast Asia 2016 PEGylated Proteins Market Share Analysis
5.5 Japan PEGylated Proteins Market Analysis
  5.5.1 Japan PEGylated Proteins Market Overview
  5.5.2 Japan 2012-2017E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Japan 2012-2017E PEGylated Proteins Sales Price Analysis
  5.5.4 Japan 2016 PEGylated Proteins Market Share Analysis
5.6 India PEGylated Proteins Market Analysis
  5.6.1 India PEGylated Proteins Market Overview
  5.6.2 India 2012-2017E PEGylated Proteins Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 India 2012-2017E PEGylated Proteins Sales Price Analysis
  5.6.4 India 2016 PEGylated Proteins Market Share Analysis

6 GLOBAL 2012-2017E PEGYLATED PROTEINS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2012-2017E PEGylated Proteins Sales by Type
6.2 Different Types of PEGylated Proteins Product Interview Price Analysis
6.3 Different Types of PEGylated Proteins Product Driving Factors Analysis
  6.3.1 Colony Stimulating Factors of PEGylated Proteins Growth Driving Factor Analysis
  6.3.2 Interferons of PEGylated Proteins Growth Driving Factor Analysis
  6.3.3 Erythropoietin (EPO) of PEGylated Proteins Growth Driving Factor Analysis
  6.3.4 Recombinant Factor Viii of PEGylated Proteins Growth Driving Factor Analysis
  6.3.5 Monoclonal Antibodies of PEGylated Proteins Growth Driving Factor Analysis
  6.3.6 Others of PEGylated Proteins Growth Driving Factor Analysis

7 GLOBAL 2012-2017E PEGYLATED PROTEINS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2012-2017E PEGylated Proteins Consumption by Application
7.2 Different Application of PEGylated Proteins Product Interview Price Analysis
7.3 Different Application of PEGylated Proteins Product Driving Factors Analysis
  7.3.1 Cancer Treatment of PEGylated Proteins Growth Driving Factor Analysis
  7.3.2 Hepatitis of PEGylated Proteins Growth Driving Factor Analysis
  7.3.3 Chronic Kidney Disease of PEGylated Proteins Growth Driving Factor Analysis
  7.3.4 Leukemia of PEGylated Proteins Growth Driving Factor Analysis
  7.3.5 SCID of PEGylated Proteins Growth Driving Factor Analysis
  7.3.6 Rheumatoid Arthritis & Crohn's Disease of PEGylated Proteins Growth Driving Factor Analysis
  7.3.7 Others of PEGylated Proteins Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF PEGYLATED PROTEINS

8.1 ENZON Pharmaceuticals
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
    8.1.2.1 Product A
    8.1.2.2 Product B
  8.1.3 ENZON Pharmaceuticals 2016 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 ENZON Pharmaceuticals 2016 PEGylated Proteins Business Region Distribution Analysis
8.2 Merck Sharp & Dohme
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
    8.2.2.1 Product A
    8.2.2.2 Product B
  8.2.3 Merck Sharp & Dohme 2016 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Merck Sharp & Dohme 2016 PEGylated Proteins Business Region Distribution Analysis
8.3 Roche
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
    8.3.2.1 Product A
    8.3.2.2 Product B
  8.3.3 Roche 2016 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 Roche 2016 PEGylated Proteins Business Region Distribution Analysis
8.4 Pfizer
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
    8.4.2.1 Product A
    8.4.2.2 Product B
  8.4.3 Pfizer 2016 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Pfizer 2016 PEGylated Proteins Business Region Distribution Analysis
8.5 Amgen
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
    8.5.2.1 Product A
    8.5.2.2 Product B
  8.5.3 Amgen 2016 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Amgen 2016 PEGylated Proteins Business Region Distribution Analysis
8.6 UCB
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
    8.6.2.1 Product A
    8.6.2.2 Product B
  8.6.3 UCB 2016 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 UCB 2016 PEGylated Proteins Business Region Distribution Analysis
8.7 Crealta (Savient)
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
    8.7.2.1 Product A
    8.7.2.2 Product B
  8.7.3 Crealta (Savient) 2016 PEGylated Proteins Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Crealta (Savient) 2016 PEGylated Proteins Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF PEGYLATED PROTEINS MARKET

9.1 Global PEGylated Proteins Market Trend Analysis
  9.1.1 Global 2017-2022 PEGylated Proteins Market Size (Volume and Value) Forecast
  9.1.2 Global 2017-2022 PEGylated Proteins Sales Price Forecast
9.2 PEGylated Proteins Regional Market Trend
  9.2.1 North America 2017-2022 PEGylated Proteins Consumption Forecast
  9.2.2 China 2017-2022 PEGylated Proteins Consumption Forecast
  9.2.3 Europe 2017-2022 PEGylated Proteins Consumption Forecast
  9.2.4 Southeast Asia 2017-2022 PEGylated Proteins Consumption Forecast
  9.2.5 Japan 2017-2022 PEGylated Proteins Consumption Forecast
  9.2.6 India 2017-2022 PEGylated Proteins Consumption Forecast
9.3 PEGylated Proteins Market Trend (Product Type)
9.4 PEGylated Proteins Market Trend (Application)

10 PEGYLATED PROTEINS MARKETING TYPE ANALYSIS

10.1 PEGylated Proteins Regional Marketing Type Analysis
10.2 PEGylated Proteins International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of PEGylated Proteins by Region
10.4 PEGylated Proteins Supply Chain Analysis

11 CONSUMERS ANALYSIS OF PEGYLATED PROTEINS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 CONCLUSION OF THE GLOBAL PEGYLATED PROTEINS MARKET PROFESSIONAL SURVEY REPORT 2017

Methodology
Analyst Introduction
Data Source


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of PEGylated Proteins
Table Product Specifications of PEGylated Proteins
Table Classification of PEGylated Proteins
Figure Global Production Market Share of PEGylated Proteins by Type in 2016
Figure Colony Stimulating Factors Picture
Table Major Manufacturers of Colony Stimulating Factors
Figure Interferons Picture
Table Major Manufacturers of Interferons
Figure Erythropoietin (EPO) Picture
Table Major Manufacturers of Erythropoietin (EPO)
Figure Recombinant Factor Viii Picture
Table Major Manufacturers of Recombinant Factor Viii
Figure Monoclonal Antibodies Picture
Table Major Manufacturers of Monoclonal Antibodies
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of PEGylated Proteins
Figure Global Consumption Volume Market Share of PEGylated Proteins by Application in 2016
Figure Cancer Treatment Examples
Table Major Consumers in Cancer Treatment
Figure Hepatitis Examples
Table Major Consumers in Hepatitis
Figure Chronic Kidney Disease Examples
Table Major Consumers in Chronic Kidney Disease
Figure Leukemia Examples
Table Major Consumers in Leukemia
Figure SCID Examples
Table Major Consumers in SCID
Figure Rheumatoid Arthritis & Crohn's Disease Examples
Table Major Consumers in Rheumatoid Arthritis & Crohn's Disease
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of PEGylated Proteins by Regions
Figure North America PEGylated Proteins Market Size (Million USD) (2012-2022)
Figure China PEGylated Proteins Market Size (Million USD) (2012-2022)
Figure Europe PEGylated Proteins Market Size (Million USD) (2012-2022)
Figure Southeast Asia PEGylated Proteins Market Size (Million USD) (2012-2022)
Figure Japan PEGylated Proteins Market Size (Million USD) (2012-2022)
Figure India PEGylated Proteins Market Size (Million USD) (2012-2022)
Table PEGylated Proteins Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of PEGylated Proteins in 2016
Figure Manufacturing Process Analysis of PEGylated Proteins
Figure Industry Chain Structure of PEGylated Proteins
Table Capacity and Commercial Production Date of Global PEGylated Proteins Major Manufacturers in 2016
Table Manufacturing Plants Distribution of Global PEGylated Proteins Major Manufacturers in 2016
Table R&D Status and Technology Source of Global PEGylated Proteins Major Manufacturers in 2016
Table Raw Materials Sources Analysis of Global PEGylated Proteins Major Manufacturers in 2016
Table Global Capacity, Sales, Price, Cost, Sales Revenue (M USD) and Gross Margin of PEGylated Proteins 2012-2017
Figure Global 2012-2017E PEGylated Proteins Market Size (Volume) and Growth Rate
Figure Global 2012-2017E PEGylated Proteins Market Size (Value) and Growth Rate
Table 2012-2017E Global PEGylated Proteins Capacity and Growth Rate
Table 2016 Global PEGylated Proteins Capacity (K MT) List (Company Segment)
Table 2012-2017E Global PEGylated Proteins Sales (K MT) and Growth Rate
Table 2016 Global PEGylated Proteins Sales (K MT) List (Company Segment)
Table 2012-2017E Global PEGylated Proteins Sales Price (USD/MT)
Table 2016 Global PEGylated Proteins Sales Price (USD/MT) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K MT) of PEGylated Proteins 2012-2017E
Figure North America 2012-2017E PEGylated Proteins Sales Price (USD/MT)
Figure North America 2016 PEGylated Proteins Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K MT) of PEGylated Proteins 2012-2017E
Figure China 2012-2017E PEGylated Proteins Sales Price (USD/MT)
Figure China 2016 PEGylated Proteins Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K MT) of PEGylated Proteins 2012-2017E
Figure Europe 2012-2017E PEGylated Proteins Sales Price (USD/MT)
Figure Europe 2016 PEGylated Proteins Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K MT) of PEGylated Proteins 2012-2017E
Figure Southeast Asia 2012-2017E PEGylated Proteins Sales Price (USD/MT)
Figure Southeast Asia 2016 PEGylated Proteins Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K MT) of PEGylated Proteins 2012-2017E
Figure Japan 2012-2017E PEGylated Proteins Sales Price (USD/MT)
Figure Japan 2016 PEGylated Proteins Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K MT) of PEGylated Proteins 2012-2017E
Figure India 2012-2017E PEGylated Proteins Sales Price (USD/MT)
Figure India 2016 PEGylated Proteins Sales Market Share
Table Global 2012-2017E PEGylated Proteins Sales (K MT) by Type
Table Different Types PEGylated Proteins Product Interview Price
Table Global 2012-2017E PEGylated Proteins Sales (K MT) by Application
Table Different Application PEGylated Proteins Product Interview Price
Table ENZON Pharmaceuticals Information List
Table Product A Overview
Table Product B Overview
Table 2016 ENZON Pharmaceuticals PEGylated Proteins Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 ENZON Pharmaceuticals PEGylated Proteins Business Region Distribution
Table Merck Sharp & Dohme Information List
Table Product A Overview
Table Product B Overview
Table 2016 Merck Sharp & Dohme PEGylated Proteins Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Merck Sharp & Dohme PEGylated Proteins Business Region Distribution
Table Roche Information List
Table Product A Overview
Table Product B Overview
Table 2015 Roche PEGylated Proteins Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Roche PEGylated Proteins Business Region Distribution
Table Pfizer Information List
Table Product A Overview
Table Product B Overview
Table 2016 Pfizer PEGylated Proteins Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Pfizer PEGylated Proteins Business Region Distribution
Table Amgen Information List
Table Product A Overview
Table Product B Overview
Table 2016 Amgen PEGylated Proteins Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Amgen PEGylated Proteins Business Region Distribution
Table UCB Information List
Table Product A Overview
Table Product B Overview
Table 2016 UCB PEGylated Proteins Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 UCB PEGylated Proteins Business Region Distribution
Table Crealta (Savient) Information List
Table Product A Overview
Table Product B Overview
Table 2016 Crealta (Savient) PEGylated Proteins Revenue (Million USD), Sales (K MT), Ex-factory Price (USD/MT)
Figure 2016 Crealta (Savient) PEGylated Proteins Business Region Distribution
Figure Global 2017-2022 PEGylated Proteins Market Size (K MT) and Growth Rate Forecast
Figure Global 2017-2022 PEGylated Proteins Market Size (Million USD) and Growth Rate Forecast
Figure Global 2017-2022 PEGylated Proteins Sales Price (USD/MT) Forecast
Figure North America 2017-2022 PEGylated Proteins Consumption Volume (K MT) and Growth Rate Forecast
Figure China 2017-2022 PEGylated Proteins Consumption Volume (K MT) and Growth Rate Forecast
Figure Europe 2017-2022 PEGylated Proteins Consumption Volume (K MT) and Growth Rate Forecast
Figure Southeast Asia 2017-2022 PEGylated Proteins Consumption Volume (K MT) and Growth Rate Forecast
Figure Japan 2017-2022 PEGylated Proteins Consumption Volume (K MT) and Growth Rate Forecast
Figure India 2017-2022 PEGylated Proteins Consumption Volume (K MT) and Growth Rate Forecast
Table Global Sales Volume (K MT) of PEGylated Proteins by Type 2017-2022
Table Global Consumption Volume (K MT) of PEGylated Proteins by Application 2017-2022
Table Traders or Distributors with Contact Information of PEGylated Proteins by Region


More Publications